PGYWW — what changed in the latest 10-Q
A section-by-section comparison of PGYWW's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-11-02 vs the prior 10-Q · 2026-07-30
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +57 | −46 | ~32 | 53 |
| Market risk (Item 3) | Text added/removed | +1 | −1 | ~4 | 9 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 1 |
| Legal proceedings | Text added/removed | +1 | 0 | ~1 | 1 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
| Other information | Text added/removed | +3 | −2 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-11-02
September 30, 2026 and 2025, our top 5 investors collectively accounted for approximately 41% and 53%, respectively, of our total funding.
Three Months Ended September 30,Nine Months Ended September 30,
Three Months Ended September 30,Nine Months Ended September 30,
Less: Net (loss) income attributable to noncontrolling interests(5,244)728 (8,716)(4,765)
(1) The following table sets forth share-based compensation for the periods indicated below (in thousands):
Text removed vs the prior filing · source: 10-Q · 2026-07-30
(1) Prior period amounts have been reclassified to conform to the current period’s presentation.
(2) The following table sets forth share-based compensation for the periods indicated below (in thousands):
Total revenue and other income, increased by $60.6 million, or 19%, to $387.0 million for the three months ended June 30, 2026, compared to $326.4 million for the three months ended June 30, 2025. The increase was primarily driven by an increase in revenue from fees and interest income.
Revenue from fees for the three months ended June 30, 2026 increased by $47.9 million, or 15%, to $365.6 million, compared to $317.7 million for the three months ended June 30, 2025. The increase was primarily due to a $32.5 million increase in Network AI fees, comprised of AI integration fees and c…
Interest income for the three months ended June 30, 2026 increased by $11.5 million, or 107%, to $22.2 million compared to $10.7 million for the three months ended June 30, 2025. The increase in interest income was directly related to our investments in loans and securities, including risk retention…
Market risk (Item 3)
Text added vs the prior filing · source: 10-Q · 2026-11-02
The fair values of these loans, securitization notes, and residual certificates are estimated based on a discounted cash flow model which involves the use of significant unobservable inputs and assumptions, the most significant of which is expected credit
Text removed vs the prior filing · source: 10-Q · 2026-07-30
The fair values of these loans, securitization notes, and residual certificates are estimated based on a discounted cash flow model which involves the use of significant unobservable inputs and assumptions, the most significant of which is expected credit losses. Accordingly, these instruments are s…
Legal proceedings
Text added vs the prior filing · source: 10-Q · 2026-11-02
litigation cannot be predicted with certainty, and regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors.
Other information
Text added vs the prior filing · source: 10-Q · 2026-11-02
On August 11, 2026, Dan Petrozzo, a director, adopted a new 10b5-1 plan with an end date of November 20, 2027, to sell up to an aggregate of 36,446 shares.
On August 11, 2026, Jonathan Dobres, the Company’s Chief Financial Officer, adopted a new 10b5-1 plan with an end date of June 30, 2028, to sell up to an aggregate of 57,093 shares.
On August 24, 2026, Gal Krubiner, a director and the Company’s Chief Executive Officer, terminated his prior 10b5-1 Plan, dated June 5, 2026, with an end date of December 31, 2026, to sell up to an aggregate of 350,000 shares. No sales occurred under the prior plan. On September 16, 2026, Mr. Krubin…
Text removed vs the prior filing · source: 10-Q · 2026-07-30
On June 2, 2026, Gal Krubiner, a director and the Company’s Chief Executive Officer, terminated his prior 10b5-1 Plan, dated March 25, 2026, with an end date of July 25, 2026, to sell a maximum aggregate of 350,000 shares. No sales occurred under the prior plan. On June 5, 2026, Mr. Krubiner entered…
On June 25, 2026, Avi Zeevi, a director, adopted a new 10b5-1 plan with an end date of December 31, 2026, to sell up to a maximum aggregate of 180,398 shares. The 10b5-1 plan also covers the sale of up to a maximum aggregate of 206,126 shares held by entities affiliated with Mr. Zeevi.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice